Enhancing fluxes through the mevalonate pathway in Saccharomyces cerevisiae by engineering the HMGR and β‐alanine metabolism. Issue 8 (9th May 2022)
- Record Type:
- Journal Article
- Title:
- Enhancing fluxes through the mevalonate pathway in Saccharomyces cerevisiae by engineering the HMGR and β‐alanine metabolism. Issue 8 (9th May 2022)
- Main Title:
- Enhancing fluxes through the mevalonate pathway in Saccharomyces cerevisiae by engineering the HMGR and β‐alanine metabolism
- Authors:
- Lu, Surui
Zhou, Chenyao
Guo, Xuena
Du, Zhengda
Cheng, Yanfei
Wang, Zhaoyue
He, Xiuping - Abstract:
- Summary: Mevalonate (MVA) pathway is the core for terpene and sterol biosynthesis, whose metabolic flux influences the synthesis efficiency of such compounds. Saccharomyces cerevisiae is an attractive chassis for the native active MVA pathway. Here, the truncated form of Enterococcus faecalis MvaE with only 3‐Hydroxy‐3‐methylglutaryl coenzyme A reductase (HMGR) activity was found to be the most effective enzyme for MVA pathway flux using squalene as the metabolic marker, resulting in 431‐fold and 9‐fold increases of squalene content in haploid and industrial yeast strains respectively. Furthermore, a positive correlation between MVA metabolic flux and β‐alanine metabolic activity was found based on a metabolomic analysis. An industrial strain SQ3‐4 with high MVA metabolic flux was constructed by combined engineering HMGR activity, NADPH regeneration, cytosolic acetyl‐CoA supply and β‐alanine metabolism. The strain was further evaluated as the chassis for terpenoids production. Strain SQ3‐4‐CPS generated from expressing β‐caryophyllene synthase in SQ3‐4 produced 11.86 ± 0.09 mg l −1 β‐caryophyllene, while strain SQ3‐5 resulted from down‐regulation of ERG1 in SQ3‐4 produced 408.88 ± 0.09 mg l −1 squalene in shake flask cultivations. Strain SQ3‐5 produced 4.94 g l −1 squalene in fed‐batch fermentation in cane molasses medium, indicating the promising potential for cost‐effective production of squalene. Abstract : The truncated form of Enterococcus faecalis MvaE with onlySummary: Mevalonate (MVA) pathway is the core for terpene and sterol biosynthesis, whose metabolic flux influences the synthesis efficiency of such compounds. Saccharomyces cerevisiae is an attractive chassis for the native active MVA pathway. Here, the truncated form of Enterococcus faecalis MvaE with only 3‐Hydroxy‐3‐methylglutaryl coenzyme A reductase (HMGR) activity was found to be the most effective enzyme for MVA pathway flux using squalene as the metabolic marker, resulting in 431‐fold and 9‐fold increases of squalene content in haploid and industrial yeast strains respectively. Furthermore, a positive correlation between MVA metabolic flux and β‐alanine metabolic activity was found based on a metabolomic analysis. An industrial strain SQ3‐4 with high MVA metabolic flux was constructed by combined engineering HMGR activity, NADPH regeneration, cytosolic acetyl‐CoA supply and β‐alanine metabolism. The strain was further evaluated as the chassis for terpenoids production. Strain SQ3‐4‐CPS generated from expressing β‐caryophyllene synthase in SQ3‐4 produced 11.86 ± 0.09 mg l −1 β‐caryophyllene, while strain SQ3‐5 resulted from down‐regulation of ERG1 in SQ3‐4 produced 408.88 ± 0.09 mg l −1 squalene in shake flask cultivations. Strain SQ3‐5 produced 4.94 g l −1 squalene in fed‐batch fermentation in cane molasses medium, indicating the promising potential for cost‐effective production of squalene. Abstract : The truncated form of Enterococcus faecalis MvaE with only 3‐Hydroxy‐3‐methylglutaryl coenzyme A reductase (HMGR) activity was found the most effective enzyme for MVA pathway flux using squalene as the metabolic marker. A positive correlation between MVA metabolic flux and alanine metabolic activity was found based on a metabolomic analysis. 4.94 g l −1 of squalene was obtained by the engineered yeast strain in fed‐batch fermentation in cane molasses medium, indicating the promising potential for cost‐effective production of squalene. … (more)
- Is Part Of:
- Microbial biotechnology. Volume 15:Issue 8(2022)
- Journal:
- Microbial biotechnology
- Issue:
- Volume 15:Issue 8(2022)
- Issue Display:
- Volume 15, Issue 8 (2022)
- Year:
- 2022
- Volume:
- 15
- Issue:
- 8
- Issue Sort Value:
- 2022-0015-0008-0000
- Page Start:
- 2292
- Page End:
- 2306
- Publication Date:
- 2022-05-09
- Subjects:
- Microbial biotechnology -- Periodicals
Biotechnology
Microbiology
660.62 - Journal URLs:
- http://ejournals.ebsco.com/direct.asp?JournalID=714890 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1751-7915 ↗
http://www.blackwellpublishing.com/mbt_enhanced/aims.asp ↗
http://www3.interscience.wiley.com/journal/118902527/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1751-7915.14072 ↗
- Languages:
- English
- ISSNs:
- 1751-7915
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5756.911050
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22776.xml